Promising disinhibition drug trial halted after just one participant
NCT ID NCT02534038
First seen May 14, 2026 · Last updated May 24, 2026 · Updated 4 times
Summary
This study tested an experimental drug called AVP-786 to see if it could safely reduce disinhibition—acting impulsively or inappropriately—in people with brain disorders like Alzheimer's or dementia. Only one person enrolled before the trial was stopped early. The main goal was to measure changes in behavior using a standard caregiver questionnaire.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISINHIBITION SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, Nevada, 89106, United States
Conditions
Explore the condition pages connected to this study.